Clinical oral implants research.
Publisher:
Munksgaard,. Copenhagen : John Wiley and Sons, Inc. (2009)
Frequency: Monthly, 2008-
Country: Denmark
Language: English
Start Year:1990 -
ISSN:
0905-7161 (Print)
1600-0501 (Electronic)
0905-7161 (Linking)
1600-0501 (Electronic)
0905-7161 (Linking)
Impact Factor
4.3
2022
| NLM ID: | 9105713 |
| (DNLM): | SR0069077(s) |
| (OCoLC): | 23657396 |
| LCCN: | sn 91033200 |
| Classification: | W1 CL758 |
Lateral alveolar ridge augmentation using an equine-derived collagen-containing bone block: A prospective case series. To assess the clinical performance of an equine-derived collagen-containing bone block (CXBB) for lateral alveolar ridge augmentation and staged implant placement. Methods: A total of n = 16 patients (16 implants) had received a modified surgical protocol for lateral ridge augmentation using a size-adapted rigidly fixed CXBB and contour augmentation. After 26 weeks of submerged healing, the primary endpoint was defined as the final ridge width (RW26) sufficient to place an adequately dimensioned titanium implant at the respective sites. Secondary outcomes included the gain in ridge width (R...
Horizontal bone grafting using equine-derived cancellous bone blocks is associated with severe complications: A prospective clinical and histological pilot study. The aim of this prospective, clinical study was to evaluate the clinical performance and histological outcome of a new equine hydroxyapatite collagenated bone block (eHAC) for horizontal bone grafting prior to implant placement. Methods: Five patients (two male/three female) with a mean age of 51.6 years (range 22-66 years) and a reduced horizontal bone width of the alveolar ridge (mean 3.5 mm) underwent horizontal bone grafting using eHAC at 10 grafting sites. Reentry was performed 6.9 months after the horizontal grafting procedure. Clinical follow-up (mean 28.9 month) considered width g...
Human osteoclast formation and activity on an equine spongy bone substitute. The aim of the present study was to evaluate the in vitro formation and activity of human osteoclasts (OCLs) generated on a new type of xenograft for bone substitution, an equine spongy bone. Methods: Peripheral blood mononuclear cells from healthy volunteers were used to generate OCLs in vitro in the presence of macrophage colony stimulating factor (M-CSF) and receptor activator of NF-kappaB ligand (RANKL) on bovine bone slices (positive control) and equine spongy bone. Morphological and biochemical methods were used to assess OCLs formation and activity. Results: Cells generated after 21 day...